PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ExplantLab, The Biosphere, Newcastle Helix, Newcastle-upon-Tyne, UK.\', \'Northumbria Healthcare NHS Trust, North Tyneside General Hospital, North Shields, Tyne and Wear, UK.\', \'Department of Medical Genetics, University of Oslo, Oslo, Norway.\', \'University Hospital of North Tees, Stockton, UK.\', \'Newcastle University Translational and Clinical Research Institute, International Centre for Life (for John Burn) and Population & Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom, for Rebecca Darlay, Newcastle-upon-Tyne, UK.\', \'Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/tan.14284
?:hasPublicationType
?:journal
  • HLA
is ?:pmid of
?:pmid
?:pmid
  • 33896121
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.438
?:rankingScore_hIndex
  • 92
is ?:relation_isRelatedTo_publication of
?:title
  • The influence of HLA genotype on the severity of COVID-19 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all